News

Vaccine Advisory Panel Holds Off on Adult PCV13 Recommendation

Publish date: February 27, 2012

 

FROM A MEETING OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

Dr. Bennett stated that she has no disclosures. Dr. Schaffner serves on the data safety monitoring board for Sanofi-Pasteur and Merck, and is an occasional consultant for Novartis, GlaxoSmithKline, and Pfizer.

Pages

Recommended Reading

Novel Meningococcal Serogroup B Vaccine is Immunogenic
MDedge Family Medicine
C. difficile Diarrhea Can Be Linked to PPIs, FDA Says
MDedge Family Medicine
Amoxicillin No Better Than Placebo for Rhinosinusitis
MDedge Family Medicine
Several Conditions Mimic Nail Fungus in Children
MDedge Family Medicine
PCV13 Works Best Against Pneumococcal Disease in Adults
MDedge Family Medicine
Oral Probiotics May Resolve Chronic Vulvovaginal Candidiasis
MDedge Family Medicine
Her Chief Complaint Is ... And by the Way She’s Also Pregnant
MDedge Family Medicine
Pertussis Immunization Recommended for Adults 65 and Older
MDedge Family Medicine
Prompt Treatment of Neonatal HSV Saves Lives
MDedge Family Medicine
U.S. 2011-2012 Flu Season Gets Late Start
MDedge Family Medicine